Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073957
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2003-12-10
Brief Title:
Y 90 Ibritumomab Tiuxetan Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkins Lymphoma
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Beth Israel Deaconess Medical Center
Organization Data
Organization:
Beth Israel Deaconess Medical Center
Class:
OTHER
Study ID:
2003P000182
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beth Israel Deaconess Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Robin Joyce
Responsible Party Title:
Assistant Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beth Israel Deaconess Medical Center
Old Name:
None
Old Organization:
None